Blog | Page 7 of 8 | Regulatory and Quality Assurance | Michelle Lott

Can you explain the difference between intended use and indications for use? The terms are NOT interchangeable, but you ...

Learn More

Blame the snake-oil salesmen. It’s mostly their fault that we ended up with so much medical device regulation in t...

Learn More

Let’s face it – no one likes being told what to do, and device manufacturers are no exception. But FDA...

Learn More

Bargaining with the FDA – or trying to – is the third stage of regulatory grief, but adopting that as...

Learn More

Always begin with the end in mind. I say this over and over in my presentations to underscore the importance...

Learn More

We as human beings are hesitant to accept change. And this pending MDR is all change. It’s gonna change your...

Learn More

News, Blogs, and Other Tidbits